Thomas F. Murray Curriculum Vitae Thomas F. Murray, Ph.D. Education: 1971—B.S. (Biology), University of North Texas, Denton, Texas 1979—Ph.D. (Pharmacology), School of Medicine, University of Washington, Seattle, Washington Brief Chronology of Employment: 1971—1973 Biology Teacher, Onondaga Central School, Nedrow, New York 1974—1976 Teaching Assistant, College of Pharmacy, Washington State University, Pullman, Washington 1976—1979 Research Assistant, Department of Pharmacology, University of Washington, Seattle, Washington (Major Professor: Akira Horita) 1979—1981 Pharmacology Research Associate, Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D.C. (Preceptor: Erminio Costa) 1981—1983 Assistant Professor of Pharmacology, College of Pharmacy, Washington State University, Pullman, Washington 1983—1986 Assistant Professor of Pharmacology, College of Pharmacy, Oregon State University, Corvallis, Oregon 1986—1990 Associate Professor of Pharmacology, College of Pharmacy, Oregon State University, Corvallis, Oregon 1990—1997 Professor of Pharmacology, College of Pharmacy, Oregon State University, Corvallis, Oregon 1997—2006 Professor and Head, Department of Physiology and Pharmacology, College of Veterinary Medicine, the University of Georgia, Athens, Georgia 2006— Professor and Chair, Department of Pharmacology, Creighton University School of Medicine, Omaha, Nebraska 2008— Associate Dean for Research, Creighton University School of Medicine, Omaha, Nebraska Societies: Sigma Xi Rho Chi Phi Kappa Phi Society for Neuroscience American Society for Pharmacology and Experimental Therapeutics Society of Toxicology Phi Zeta 1 Thomas F. Murray Professional Honors and Appointments: 1976—1979 National Institute on Drug Abuse Predoctoral Fellowship 1979—1981 National Institute of General Medical Sciences Pharmacology Research Associate Training Fellowship 1990 Ad hoc Member, National Institute on Drug Abuse Biomedical Review Research Committee 1990 Ad hoc Member, National Institute on Drug Abuse Special Review Committee Designer Drug Induced Neuropathology 1993 Ad hoc Member, National Institute on Drug Abuse Special Review Committee 1990—1994 Member, National Institute on Drug Abuse – Biomedical Research Review Committee 1994 Ad hoc Member, National Institute on Drug Abuse Special Review Committee – Human Basic and Clinical Neuroscience of Drug Addiction 1993—1997 Member, American Heart Association-Oregon/Washington Affiliate, Research Peer Review Committee 2000—2002 Ad hoc Member, NIH Integrative, Functional and Cognitive Neuroscience Committee 2001—2007 Distinguished Research Professor, the University of Georgia 2004—2007 Ad hoc Member, NIDA-K Training and Career Development Review Committee 2007—2011 Member, NIDA-K Training and Career Development Review Committee 2008---2009 Ad hoc Member, NIH, Brain Disorders and Related Neuroscience Fellowships Review Committee University Committees Chaired: 1988—1990 Radiation Safety Committee Oregon State University 1989—1993 Graduate Studies and Research Committee College of Pharmacy Oregon State University 1991 Pharmacology Search Committee College of Pharmacy Oregon State University 1992 Pharmacology Search Committee College of Pharmacy Oregon State University 1992—1993 Space Utilization and Planning Committee College of Pharmacy Oregon State University 1994 Toxicology Program Chair Search Committee Oregon State University 1995—1997 Faculty Senate Library Committee Oregon State University 1995—1997 Tenure and Promotion Committee College of Pharmacy Oregon State University 2 Thomas F. Murray 1998 Chair, Ad hoc Committee for Budgeted College of Veterinary Medicine Assignment of Time Policy The University of Georgia 2001 Chair, Department of Medical Microbiology College of Veterinary Medicine And Parasitology Headship Search Committee The University of Georgia 2004 Chair, Long Range Planning College of Veterinary Medicine and Facilities Committee The University of Georgia 2005 External Reviewer College of Veterinary Medicine Department of Biomedical Sciences Iowa State University 2005 Chair, External Review Committee East Carolina University Department of Pharmacology Brody School of Medicine 1997—2006 Head College of Veterinary Medicine Department of Physiology and Pharmacology The University of Georgia 2004—2006 Member, Research Advisory Council The University of Georgia Office of the Vice President for Research 2006—present Member, Financial Advisory Committee Creighton University School of Medicine 2006—present Member, Leadership Council Creighton University School of Medicine 2006—present Member, Executive Committee Creighton University School of Medicine 2006—2008 Member, Research Planning Committee Creighton University School of Medicine 2007—present Member, IACUC Creighton University 2008—present Associate Dean for Research Creighton University School of Medicine Invited Lectureships: 1. National Drug Abuse Conference, Seattle, WA, April, 1978. “Behavioral Pharmacology of Phencyclidine.” 2. National Institute on Drug Abuse Research Fellows Conference, Washington, D.C. August, 1979. “Cholinergic Influences on the Pharmacological Effects of Δ9-THC.” 3. Joint French-U.S. Seminar on the Chemistry, Pharmacology, Toxicology, Therapy and Drug Abuse Aspects of Arylcyclohexylamines, LaGrande Motte, France, September 20–24, 1982. “Acute and Chronic Effects of Phencyclidine on Cholinergic Dynamics in Various Rat Brain Structures.” 4. Seminar entitled “Modulation of Cholinergic Dynamics in Rat Brain by Intracerebroventricular Administration of Adenosine Analogs”, at the Department of Pharmacology, School of Medicine, Oregon Health Sciences University, Portland, Oregon, March 15, 1983. 5. Collegium Internationale Neuropsychopharmacologicum, Symposium on “Adenosine Receptors and Methylxanthines in the CNS,” Florence, Italy, June 19–23, 1984. “Adenosine Receptor Mediated Modulation of Seizure Threshold in the Rat.” 3 Thomas F. Murray 6. Seminar entitled “Purinergic Modulation of Transmitter Dynamics and Seizure Threshold”, at the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington, November 9, 1984. 7. Third Workshop on Neurotransmitters in Epilepsy, Soverato, Italy, September 17–19, 1985. “A1 Adenosine Receptor Mediated Modulation of Seizure Threshold.” 8. Seminar entitled “Muscarinic Cholinergic Receptor in Marine Invertebrates: Implications for Learning”, at the Department of Medical Psychology, University of Calgary, Calgary, Alberta, Canada, February 27, 1986. 9. American Chemical Society Symposium on Bioactive Mechanisms: Proof, SAR and Prediction, Los Angeles, California, September 28, 1988. “A1 Adenosine Receptors in Heart: Functional and Biochemical Consequences of Activation.” 10. Fourth Workshop on Neurotransmitters in Epilepsy, Stresa, Italy, October 9–12, 1988. “A1 Adenosine Receptors Express Anticonvulsant Activity in Rat Prepiriform Cortex.” 11. Symposium on “Pharmacology, Biochemistry and Function of Adenosine Receptors” at 32nd Annual Meeting of the Western Pharmacology Society, Breckenridge, CO., January 1989 (Organizer and Chair). 12. Seminar entitled “Biochemical and Functional Characterization of A1 Adenosine Receptors” at the Department of Pharmacology, University of Alberta, Edmonton, Calgary, July 7, 1989. 13. Purine Nucleosides and Nucleotides in Cell Signaling: Targets for New Drugs, Rockville, M.D., September 17–20, 1989. “Agonist and Antagonist Radioligand Interactions with the Solubilized Porcine Atrial A1 Adenosine Receptor.” 14. Fourth International Symposium on Adenosine and Adenine Nucleotides, Lake Yamanaka, Japan, May 13– 17, 1990. “Biochemical and Pharmacological Characterization of A1 Adenosine Receptors.” 15. French-U.S. Joint Seminar on Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Protection? La Grande Motte, France, September 15–19, 1991. “High Affinity [3H]Dextrorphan Recognition Site of the NMDA Operated Cation Channel Mediates the Anticonvulsant Actions of Dextrorotatory Opioids and Phencyclidine. 16. Seminar entitled “Endogenous Adenosine as an Anticonvulsant” at the Department of Pharmacology, School of Medicine, University of Nevada Reno, March 5, 1992. 17. Seminar entitled “Manipulation of Endogenous Adenosine Affects Seizure Susceptibility” at Abbott Laboratories, Abbot Park, Illinois, August 27, 1992. 18. Fifth International Symposium on Adenosine and Adenine Nucleotides, Philadelphia, PA, May 9–13, 1994. “P2 Purinoceptor Agonists Elicit Behavioral Seizures in the Rat Prepiriform Cortex.” 19. Eighth International Symposium on Purine and Pyrimidine Metabolism, Bloomington, ID, May 1994. “Pathways of Adenosine Formation, Metabolism and Transport as Targets for Modulation of Seizure Susceptibility. 20. Seminar entitled, “Dextrorotatory Opioid Interaction with NMDA Receptors: What Can Dextromethorphan Do for You” at the School of Pharmacy, University of Montana, Missoula, MT, March 14, 1997. 21. Gordon Research Conference on Mycotoxins and Phycotoxins, Plymouth, NH, June 20-24, 1999. “Brevetoxin Induction of Neurotoxicity in Cultured Cerebellar Granule Cells.” 4 Thomas F. Murray 22. Seminar entitled, “NMDA Receptors as Molecular Targets for Marine Biotoxins and Dextrorotatory Opioids” at the Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, June 11, 2001. 23. Seminar entitled “NMDA Receptors as Molecular Targets for Dextrorotatory Opioids” at the Department of Physiology